GENITAL HEALTH
GENITAL HEALTH TEST OFFERING
As Sexually Transmitted Infections (STIs) continue to surge, Eurofins Diatherix is here to support you in delivering timely and effective patient care providing
The Right Test for the Right Time
Eurofins Diatherix's proprietary TEM-PCR™ technology and expertise ensures accurate, actionable results, allowing you to take proactive steps toward patient recovery. Our rapid testing and reporting services enable you to swiftly implement treatment plans for STIs such as chlamydia, gonorrhea, HSV 1 &2, and trichomonas. Our test menu currently includes 9 tests under Genital Health. The menu is designed to offer single-target tests or panels when necessary for screening or symptomatic testing. Our unique technology allows for early detection of symptomatic patients without the need for phlebotomy. Addresses a gap in patient care between presentation, symptoms, and seropositivity.
With Eurofins-Diatherix, you gain access to reliable and comprehensive STI testing that empowers you to make informed decisions for your patient.
Our proprietary TEM-PCR™ technology and expertise ensure accurate, actionable results, allowing you to take proactive steps toward patient recovery.
Eurofins Diatherix offers a comfortable dirty catch urine collection method for most genital health testing and a seamless testing process ensuring prompt intervention when necessary. To safeguard accurate results, Eurofins Diatherix STI tests include a host control to ensure the specimen has a sufficient number of epithelial cells in the specimen to prevent a "false negative" result.
By utilizing Eurofins Diatherix services, you can provide your patients with the highest standard of care and contribute to combating STI transmissions.
Partner with Eurofins Diatherix and confidently develop patient treatment plans based on our fast and accurate testing.
Proprietary TEM-PCR™ improves the success of an accurate clinical diagnosis with the following benefits:
- Optimizes target amplification conditions that improve both sensitivity and specificity of difficult-to-identify pathogens
- Improves the identification of infectious organisms in patients who are already on empirical antibiotic regimens
- Identifies both viruses and bacteria that have synergistic roles in more complex infections
Accurate detection and co-detection of problematic bacteria and viruses can result in significant improvements during the patient treatment process. Having this precise knowledge can allow the clinician to determine the right course of action and preclude inappropriate antibiotic therapy.
- Delivers next-day results
- Identifies bacteria regardless of recent antibiotic use
- Offers simplicity of single-sample collection
- Identifies difficult-to-culture pathogens
- Yields a high level of sensitivity and specificity
The Eurofins Diatherix Research and Development Team strives to be dynamic and nimble by developing solutions to improve patient outcomes through the application of Eurofins Diatherix TEM-PCR™ and related technologies. The R&D Team drives the development of these new tests by listening to feedback from clinicians, identifying unmet needs, and delivering to medical care providers solutions with which they can better serve their patients. All tests are monitored on a recurrent basis to ensure content is current and inclusive of new and emerging strains.
Partner with Eurofins Diatherix to enhance your diagnostic capabilities and provide the best care to your patients.
PLEASE CLICK LINK BELOW FOR FULL TEST MENU
PLEASE CLICK LINK BELOW FOR ACCEPTABLE SPECIMEN TYPES
PLEASE CLICK LINK BELOW FOR SAMPLE TEST REPORT